Xeris Biopharma Holdings
XERS
XERS
199 hedge funds and large institutions have $477M invested in Xeris Biopharma Holdings in 2025 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 73 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
23% more funds holding
Funds holding: 162 → 199 (+37)
12.3% more ownership
Funds ownership: 44.08% → 56.39% (+12%)
Holders
199
Holding in Top 10
3
Calls
$2.44M
Puts
$537K
Top Buyers
| 1 | +$9.27M | |
| 2 | +$7.75M | |
| 3 | +$7.6M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$7.42M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$6.6M |
Top Sellers
| 1 | -$8.73M | |
| 2 | -$6.83M | |
| 3 | -$4.78M | |
| 4 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$3.34M |
| 5 |
AGM
Alpine Global Management
New York
|
-$1.21M |
